fda warning letters compounding semaglutide october 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Hims & Hers' Woes Compound

However, therapy with cisplatin is notably limited by a toxicity mechanism in the non-dividing proximal tubule cells of the kidney that is distinct from DNA cross-linking

More Research Questions As researchers map GLP-1 receptor distribution, they are also searching for unifying mechanisms that could explain the drugs systemic effects

Image Credit: zimmytws / Shutterstock In a recent study published in the journal Diabetes, Obesity, and Metabolism , researchers evaluated clinical outcomes with oral semaglutide treatment in type 2 diabetes (T2D) patients

The first one or two shots will not give you that immediate improvement you might expect